Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 14thInternational Conference on Clinical and Experimental Dermatology Philadelphia ,USA.

Day 1 :

Keynote Forum

Regina Folster-Holst

University Medical Center Schleswig-Holstein
Germany

Keynote: Epidermal barrier in patients with atopic dermatitis and ichthyosis

Time : 09:30-10:00

OMICS International Dermatology 2017 International Conference Keynote Speaker Regina Folster-Holst photo
Biography:

Regina Folster-Holst has completed her PhD in 1984 from Christian Albrechts University, Germany. After a Medical Assistant time in a children's clinic for cystic fibrosis and allergy at Amrum, Germany in November 1985, she began her specialist training for Dermatologists at the Department of Dermatology, Kiel, Germany. In 1992, she was recognized as a Specialist in Dermatology and Allergology. Since 1992, she has been working as a Senior Physician at the University Medical Center Schleswig-Holstein, Department of Dermatology in Kiel, Germany. Her clinical activity and research priority is primarily in the area of Atopic Dermatitis, Pediatric Dermatology and Parasitosis. She has published more than 160 papers in reputed journals. Since May 2016, she is the President of the European Society for Pediatric Dermatology (ESPD).

Abstract:

An intact epidermal barrier is essential. On the one hand it ensures hydration of the skin and on the other it prevents penetration of harmful substances from the environment like allergens, infectious agents and pollutants. There are many skin diseases showing defects of the skin barrier, which is localized in the stratum corneum and consists of protein-rich cells and a lipid-enriched intercellular space. Prime examples are atopic dermatitis and ichthyoses. Atopic dermatitis is the result of complex interactions of genetic and environmental factors, which influence the epidermal structure and function, as well as the immune system. Ichthyoses are genodermatoses characterized by scaling and in many cases also by erythroderma. We focus the epidermal barrier in atopic dermatitis, ichthyosis vulgaris and Netherton syndrome. The latter is a rare autosomal recessive disorder of cornification, characterized by the triad of ichthyosis, hair shaft anomalies and atopy. The syndrome is present at birth or soon after with generalized exfoliative erythroderma, with or without an atopic diathesis. The quality of the skin barrier can be assessed by using a new semi-quantitative method to measure intercellular lipid lamellae (lipbarvisR). We used this non-invasive skin sampling technique also to evaluate the influence of emollients and also the topical application of drugs like corticosteroid and calcineurin inhibitors. In addition, we investigate the shape of the corneocytes in the upper SC and we found that the undulation of the corneocyte membranes differs between the investigated skin types. Highly undulated corneocyte membranes were visible in Netherton syndrome, little less undulation of the corneocytes in skin samples with ichthyosis vulgaris, and a lesser extent undulation as in skin samples of AD.

Keynote Forum

Pamela R Springer

Global Skin Solutions, LLC
USA

Keynote: Reduced risk and enhanced results for skin color

Time : 10:00-10:30

OMICS International Dermatology 2017 International Conference Keynote Speaker Pamela R Springer photo
Biography:

Pamela R Springer is an author, contributor to industry publications and a book reviewer for Milady’s publishing, with over 20 years of experience working with multi-ethnic skin. She has been a Subject Matter Expert for the National Council of State Boards of Cosmetology, Inc. (NIC) and was the first Aesthetician on the Arizona Board of Cosmetology. Since the 90s, she has conducted hands-on training workshops in cities throughout the United States.

Abstract:

The goal of this activity is for health care and wellness providers to develop a greater understanding of the importance of lessening the risk factor when developing skin treatment plans or consulting with individuals regarding basic or advanced skin care treatments. The heart of the presentation is the development of a personal skin profile based on observation and quantitative methods. A consultation is the key to a truly comprehensive skin assessment in this way supports not only skin health but the early identification of potential skin cancer risks.

Keynote Forum

Neil Sandhu

Daystar Skin and Cancer Center
USA

Keynote: Most Current and up to date treatment options for non-melanoma skin cancers

Time : 10:50-11:20

OMICS International Dermatology 2017 International Conference Keynote Speaker Neil Sandhu photo
Biography:

Neil Sandhu, MD, is a Board-Certified Dermatologist (ABD) and is the medical director for Daystar Skin and Cancer Center. Dr. Sandhu served as Chief Resident at UMDNJ-New Jersey Medical School. His training puts him at the cutting-edge in cosmetic dermatology and skin cancer surgery. Dr. Sandhu is also trained in cosmetic procedures including BOTOX and filler injections, chemical peels, and photorejuvenation. Dr. Sandhu attended the University of Wisconsin, where he graduated Summa Cum Laude before going on to attend the University of Wisconsin School of Medicine & Public Health, where he again graduated at the top of his class. Dr. Sandhu has authored multiple scientific articles, including one focusing on the use of laser procedures in dermatology. He is a member of the American Society for Dermatologic Surgery and the American Society of Mohs Surgery.

Abstract:

Nonmelanoma skin cancer (NMSC) are the most common type of cancer amongst the Caucasian population. Basal cell carcinoma and squamous cell carcinoma are the two types of non-melanoma skin cancers. These skin cancers require treatment with Mohs Surgery, excision, superficial radiotherapy, cryosurgery, Electrodessication and curettage, Blu-U light treatment Imiquimod, or 5-Flurouracil.  Mohs surgery is the most effective treatment for all types of BCC and SCC greater than 2cm in diameter.  Mohs surgery cure rate is 97% for SCC and 99% for BCC.  Standard excisions are performed on BCC and SCC less than 2 cm in diameter.  The cure rate for a standard excision is 98% for BCC and 95% for SCC.  Electrodissection and cautery is performed by using a sharp ring curette instrument to remove the epidermis and dermis that contains cancer cells. Then you use electrocautery to char the base of the wound. This is best used to treat low risk NMSC.  Superficial radiotherapy is a noninvasive low energy radiotherapy that penetrates only a short distance below the surface of the skin.  This is best for people who are not candidates for surgery.  Cryotherapy involves using a device that sprays liquid nitrogen to freeze and then thaw the areas of concern causing a local cellular destruction. This is used for superficial BCC and in situ SCC.  Imiquimoid and topical 5-Fluorouracil (5FU) are best used for superficial BCC but not for SCC. Lastly, the Blu-U light treatment is best used for actinic keratosis (AK), which are pre-cancerous. After application of Levulan Kerastick to the AKs, exposure to the Blu light causes a reaction to occur which destroys the AK cells.